(+)(S)-3-乙酰氧基-2-甲基丁烷 | 56640-64-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: (+)(S)-3-乙酰氧基-2-甲基丁烷
• 英文名称: (+)(S)-3-acetoxy-2-methyl-butane
• 英文别名: (+)(S)-3-Acetoxy-2-methyl-butan；(s)-1,2-Dimethylpropyl ethanoate；[(2S)-3-methylbutan-2-yl] acetate
• CAS: 56640-64-3
• 化学式: C₇H₁₄O₂
• 分子量: 130.187
• InChiKey: ZLSXRPTWWRGMTJ-LURJTMIESA-N

物化性质

• 沸点：
  122.4±8.0 °C(Predicted)
• 密度：
  0.877±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  (+)-3-甲基-2-丁醇 、 乙酸酐 在 吡啶 作用下， 生成 (+)(S)-3-乙酰氧基-2-甲基丁烷
  参考文献：
  名称：

  The Influence of Branched Chains on Optical Activity. The Configuration of Methyl-tertiary-butylcarbinol

  摘要：

  DOI：

  10.1021/ja01337a061

文献信息

• HETEROCYCLIC CETP INHIBITORS
  申请人：Salvati E. Mark

  公开号：US20070161685A1

  公开（公告）日：2007-07-12

  Compounds of formula Ia and Ib wherein A, B, C and R 1 are described herein.

  式Ia和Ib的化合物 其中A、B、C和R1 如本文所述。
• Catalytic Properties of Lipases Immobilized on Various Mesoporous Silicates
  作者：Katsuya KATO、Roxana IRIMESCU、Takao SAITO、Yoshiyuki YOKOGAWA、Haruo TAKAHASHI

  DOI：10.1271/bbb.67.203

  日期：2003.1

  Lipases SP525, AK, LIP, and PS were immobilized on three kinds of mesoporous silicates (FMS, PESO, and SBA) with diameters of 27 to 92 Å. The amount of lipase activity adsorbed on these supports was related to the pore size of the silicate. Enantioselectivities of immobilized lipases were similar to those of free lipases, and recycling could be done in both aqueous and organic solvents.

  脂肪酶SP525、AK、LIP和PS被固定在三种中孔硅酸盐（FMS、PESO和SBA）上，其孔径介于27至92 Å之间。吸附在这些载体上的脂肪酶活性量与硅酸盐的孔径大小有关。固定化脂肪酶的对映选择性与游离脂肪酶相似，并且可以在水相和有机溶剂中循环使用。
• IMIDAZOLYL ANALOGS AS SYK INHIBITORS
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20150175575A1

  公开（公告）日：2015-06-25

  The present invention provides novel imidazole analogs of Formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.

  本发明提供了一种新型咪唑类似物I的化合物，它们是脾酪氨酸激酶的有效抑制剂，可用于治疗和预防由该酶介导的疾病，如哮喘、COPD、类风湿性关节炎和癌症。
• PYRAZOLYL DERIVATIVES AS SYK INHIBITORS
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20150191461A1

  公开（公告）日：2015-07-09

  The present invention provides novel pyrazole derivatives of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.

  本发明提供了公式I的新型吡唑衍生物，它们是脾酪氨酸激酶的有效抑制剂，并可用于治疗和预防由该酶介导的疾病，如哮喘、慢性阻塞性肺疾病、类风湿性关节炎和癌症。
• Asymmetric transesterification of secondary alcohols catalyzed by feruloyl esterase from Humicola insolens
  作者：Nikos S. Hatzakis、Ioulia Smonou

  DOI：10.1016/j.bioorg.2005.05.002

  日期：2005.8

  A new asymmetric transesterification of secondary alcohols catalyzed by feruloyl esterase from Humicola insolens has been found. Although alcohols are not the natural substrates for this enzyme, a high R enantioselectivity was observed. Stereochemical studies showed that variations in substrate structure lead to strong variations in enantioselectivity. The highest enantioselectivities are obtained when the beta-carbon of the secondary alcohol is tertiary or quaternary. (c) 2005 Elsevier Inc. All rights reserved.